dihexa clinical trials humans Sublingual BPC-157 dihexa clinical trial humans human

10.1038/224143a0 523 SchrammA.BignonC.BroccaS.GrandoriR.SantambrogioC.LonghiS

Top image credit: Cixia Bottom image credit: Tim Kubacki Drug rash Matibot / Wikimedia Commons What it looks like : Drug rashes are usually speckled, itchy, and red, and can cover large areas of skin

Longevity therapy support 60mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 150 Reg | 120 Club Longevity therapy support 80mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 190 Reg | 152 Club Longevity therapy support 100mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 200 Reg | 160 Club Longevity therapy support 150mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 250 Reg | 200 Club Longevity therapy support 200mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 300 Reg | 240 Club Longevity therapy support 300mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 400 Reg | 320 Club Longevity therapy support 400mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 500 Reg | 400 Club Longevity therapy support 500mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 600 Reg | 480 Club Longevity therapy support 750mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 725 Reg | 580 Club Longevity therapy support 1000mg of NAD+ (Nicotinamide Adenine Dinucleotide) in 100ml of Saline 850 Reg | 680 Club NAD+ Services NAD+ Injections NAD+ injections offer a fast, effective way to replenish your bodys natural NAD+ levels

Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2

A doctor who ignores these signals and continues to prescribe or recommend BPC-157 is not just breaking the rules but potentially betraying patient trust